Senate Republicans on Tuesday displayed a shift in attitude toward pharmaceutical companies as they questioned seven top CEOs in a hearing about why their products have become so expensive, signaling they will work to pass new drug pricing laws.

The shift comes as polling shows that prescription drug costs top voters’ concerns about healthcare and as headlines about soaring prices of lifesaving medicines permeate the news.